National Kidney Foundation Releases Voice of the Patient Report on Kidney Xenotransplantation Based on EL-PFDD meeting. NEW YORK, Dec. 17, 2024 /PRNewswire/ -- Pig kidneys may be the key to ...

EL-PFDD meetings are a part of the FDA’s Patient-Focused Drug Development (PFDD) program, which aims to systematically obtain the patient perspective on specific diseases and their treatments.

On September 25, 2017, the Lupus Foundation of America partnered with the Lupus and Allied Diseases Association and the Lupus Research Alliance to host an externally-led patient focused drug ...